iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionRehmann Capital Advisory Group
Latest Disclosed Ownership1,693 shares
Latest Disclosed Value $ 285,893
Rehmann Capital Advisory Group ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Rehmann Capital Advisory Group filed a 13F-HR form disclosing ownership of 1,693 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $285,893 USD as of March 31, 2026. The entity filed a previous 13F-HR on March 4, 2026 disclosing 1,693 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $221,868 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,693 0 0.00 286 0.00 0.0149
2026-03-04 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,693 -1 -0.06 286 16.80 0.0149
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,694 0 0.00 245 14.02 0.0134
2025-07-30 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,694 -296 -14.87 214 -15.75 0.0130
2025-04-30 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,990 1 0.05 255 -3.42 0.0160
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,989 -473 -19.21 263 -26.54 0.0167
2024-11-18 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,462 -66 -2.61 359 3.17 0.0234
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,528 2,528 347 0.0249
2022-06-03 2022-03-31 13F ISHARES TR IBB 464287556 0 -2,207 -100.00 0 -100.00
2022-03-02 2021-12-31 13F ISHARES TR IBB 464287556 2,207 -61 -2.69 337 -8.20 0.0313
2021-11-16 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,268 -2,757 -54.87 367 -55.80 0.0347
2021-08-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,025 2,168 75.88 828 92.56 0.0801
2021-05-26 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,857 62 2.22 430 1.65 0.0440
2021-02-19 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,795 593 26.93 423 41.95 0.0478
2020-11-19 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,202 31 1.43 298 0.68 0.0378
2020-11-20 2020-06-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 2,171 2,171 297 0.0405
2020-01-02 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -2,450 -100.00 0 -100.00
2019-08-27 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,450 970 65.54 267 61.82 0.0329
2019-05-22 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,480 602 68.56 166 96.43 0.0224
2019-02-12 2018-12-31 13F ISHARES NASDAQ NASDAQ BIOTECH 464287556 878 -988 -52.95 85 -63.00 0.0127
2018-12-07 2018-09-30 13F/A-1 ISHARESTR NASDAQBIOTECH 464287556 1,866 -332 -15.10 228 -5.81 0.0314
2018-09-20 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,198 353 19.13 241 22.34 0.0350
2018-04-24 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,845 1,845 197 0.0307
2017-07-19 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -817 -100.00 0 -100.00
2017-04-24 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 817 -34 -4.00 240 6.19 0.0401
2017-02-13 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 851 851 226 0.0414
2016-02-11 2015-12-31 13F ISHARES NASDQ BIOTEC ETF 464287556 0 0 0 0.0000
2015-11-12 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -596 -100.00 0 -100.00
2015-07-08 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 596 -189 -24.08 220 -18.22 0.0502
2015-04-14 2015-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 785 46 6.22 269 20.09 0.0610
2015-03-09 2014-12-31 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 739 -178 -19.41 224 -10.76 0.0516
2015-09-01 2014-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 917 -32 -3.37 251 2.87 0.0594
2015-09-01 2014-06-30 13F ISHARES NASDQ BIOTEC ETF 464287556 949 949 244 0.0583
2015-08-31 2014-03-31 13F ISHARES NASDQ BIOTEC ETF 464287556 0 -928 -100.00 0 -100.00
2015-08-31 2013-12-31 13F ISHARES NASDQ BIOTEC ETF 464287556 928 -404 -30.33 211 -24.37 0.0638
2015-08-31 2013-09-30 13F ISHARES NASDQ BIOTEC ETF 464287556 1,332 1,332 279 0.0903
2015-08-31 2012-12-31 13F ISHARES TR NASDQ BIO INDX 464287556 0 -1,542 -100.00 0 -100.00
2015-08-31 2012-09-30 13F ISHARES TR NASDQ BIO INDX 464287556 1,542 -428 -21.73 220 -14.06 0.0808
2015-08-31 2012-06-30 13F ISHARES TR NASDQ BIO INDX 464287556 1,970 1,970 256 0.0841
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.